Credo

Credo

Automates medical record retrieval for providers

Overview

Credo Health provides an automated medical record retrieval platform for healthcare providers and payers, using interoperable standards to digitally automate end-to-end retrieval. It connects to multiple data sources, collects records, and delivers a complete, accurate patient record before the first visit so clinicians can start with full information. It differentiates itself through end-to-end automation via standardized interoperability rules and a subscription-based model with potential premium features, reducing risks and costs. Its goal is to improve compliance, clinical understanding, and patient outcomes by ensuring timely, complete records at the point of care.

Significant Headcount Growth

About Credo

Simplify's Rating
Why Credo is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

Healthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$8.3M

Headquarters

Sacramento, California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Value-based care adoption accelerating, driving demand for risk adjustment capabilities.
  • MSO and ACO consolidation creates embedding opportunities in larger networks.
  • EHR integration partnerships with Vim reduce implementation friction and increase stickiness.

What critics are saying

  • Epic's native AI Copilot embedded in 60% of US EHRs directly displaces Credo.
  • PicnicHealth's FHIR platform captures 40% more complete records than Acquire.
  • CMS TEFCA compliance fines effective July 2026 threaten 20-30% revenue loss.

What makes Credo unique

  • Combines digital and manual medical record retrieval with AI analysis uniquely.
  • PreDx addresses 30-50% non-digital chart gap competitors systematically miss.
  • Delivers 80%+ cost reduction in chart preparation for healthcare organizations.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$8.3M

Above

Industry Average

Funded Over

2 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$5.3M
Credo

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

2%

2 year growth

5%
Stock Titan
Apr 13th, 2026
A $750M deal gives Credo silicon photonics tech for AI networks

DustPhotonics adds PIC technology for 400G to 3.2T optics. Credo sees $500M+ optical revenue in fiscal 2027; closing is expected in Q2 2026.

Cision
Jan 5th, 2024
Credo Health Announces Oversubscribed $5.25 Million Series Seed Funding

"This investment is a testament to our commitment to fully support providers with the technology they need to succeed in value-based care," says Credo Founder and CEO Carm Huntress. .

Cision
Mar 27th, 2023
Credo Unveils Predx - The First Pre-Encounter Patient Summary Solution

Our solution not only improves patient outcomes, but directly affects providers' ability to accurately diagnose complex patients and speed up time to effective treatment. .

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Credo right now.

Find jobs on Simplify and start your career today

We update Credo's jobs every few hours, so check again soon! Browse all jobs →